MedTrace Logo

Mobile Phone Text for Optimizing Asthma Treatment

NCT00917410 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 244

Last updated 2009-06-10

No results posted yet for this study

Summary

The study aims at providing information on how the Short Message Service (SMS) tool influences self-management in asthma patients and to assess the resulting health related effect. A wide range of models and theories exist in the compliance area, such as technical models, communication models, cognitive models and self-management models and theories. The use of some of these theories and models will serve as theoretical and explanatory tools for studying how and why the SMS tool influences the patient's self-management.

Objective:

The objective of this study is to assess the health-related effects of a SMS compliance and monitoring system for optimized asthma treatment in a controlled trial setting.

Conditions

Interventions

BEHAVIORAL

SMS support

The intervention consisted of sequences of SMS messages sent to the intervention group, each containing 2 or 3 monitoring questions and one reminder to take the preventive medication. The SMS sequence was as follows. 1. Remember to take your preventive asthma medication (sent at 8.00 am). 2. Were you awakened during the night due to your asthma? Answer YES or NO. 3. How many times have you taken your asthma attack medication during the last 24 hours? Answer a number. 4. What was your peak flow this morning? Answer a number (optional, depending on the participant's use of a spirometer prior to the study).

Sponsors & Collaborators

  • MedicoMonitor Aps

    collaborator UNKNOWN

  • The Ministry of Health and Prevention, Denmark

    collaborator OTHER_GOV

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Claus Møldrup, PhD · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00917410 on ClinicalTrials.gov